About Gemini Bioproducts Holding
Gemini Bioproducts Holding is a private company based in West Sacramento, California. It has reported $25,675,000 raised in four offerings on Form D since May 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 10, 2024 | May 23, 2024amended Nov 27, 2024 | $5,675,000of $7.0M target | 21 | $270K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 8, 2023 | Sep 19, 2023 | $1,500,000fully sold | 7 | $214K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 29, 2023 | Apr 12, 2023 | $3,500,000fully sold | 13 | $269K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 12, 2022 | May 26, 2022 | $15,000,000fully sold | 21 | $714K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, four offerings | $25,675,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gemini Bioproducts Holding's Form D filed Nov 27, 2024.
MG
Michael Guerra
Director
BP
Brian Parker
Executive officer and director
AL
SS
Steven Sandoval, Sr.
Director
HB
JW
GN
Gopi Natarajan
Director
CS
Cory Stevenson
Director
BP
Bryan Poltilove
Director
EM
Edwin Mendham
Executive officer
DD
Earlier filings also listed Gopi Natajaran (director, last listed Sep 2023), Ted Ayliffe (director, last listed May 2022) and Anthony Lee (executive officer and director, last listed May 2022).